Beema T Yoosuf

About

PhD Scholar

Employment

• National Institute of Pharmaceutical Education and Research PhD Research Scholar
  2021 - Present
• IQVIA (India) Drug Safety Associate Trainee
  2021 - 2021

Education

• National Institute of Pharmaceutical Education and Research PhD
  2021 - Present

Projects & Funding

Projects & funding information is unavailable.

Publications (15)

• Safety Profile of Istradefylline in Parkinson’s Disease: A Meta-Analysis of Randomized Controlled Trials and Disproportionality Analysis Using FAERS
  Journal of Geriatric Psychiatry and Neurology 2026 DOI: 10.1177/08919887251343608
  +Save
• Comprehensive safety profile of dipeptidyl peptidase-4 inhibitors: a post-marketing study based on FAERS database using signal detection algorithms
  Expert Opinion on Drug Safety 2025 DOI: 10.1080/14740338.2024.2343015
  +Save
• Epidemiology, transmission dynamics, treatment strategies, and future perspectives on Oropouche virus
  Diagnostic Microbiology and Infectious Disease 2025 DOI: 10.1016/j.diagmicrobio.2025.116882
  +Save
• Risk of genitourinary tract infections with SGLT-2 inhibitors in type 2 diabetes mellitus: A meta-analysis of randomised controlled trials and disproportionality analysis using FAERS
  Endocrine 2025 DOI: 10.1007/s12020-025-04393-7
  +Save
• Cardiac Adverse Events Associated With Elotuzumab: A Disproportionality Analysis Using FDA Adverse Event Reporting System
  Annals of Pharmacotherapy 2025
  +Save
• Vorasidenib: A Milestone in Targeted Therapy for IDH-Mutant Lower Grade Gliomas - Efficacy, Emerging Safety Concerns, and the Call for Comprehensive Safety Evaluation
  Current Drug Safety 2025 DOI: 10.2174/0115748863355533241202110934
  +Save
• Concerns and implications of Oropouche virus infection during pregnancy: A call for further research and public health action
  New Microbes and New Infections 2025 DOI: 10.1016/j.nmni.2024.101549
  +Save
• Insights into the systemic risk factors associated with diabetic retinopathy in the Indian population: A comprehensive systematic review and meta-analysis
  Indian Journal of Ophthalmology 2025 DOI: 10.4103/IJO.IJO_818_24
  +Save
• Comprehensive safety evaluation of isatuximab in multiple myeloma using disproportionality analysis of FAERS and meta-analysis of randomized controlled trials
  Scientific Reports 2024 DOI: 10.1038/s41598-024-83014-1
  +Save
• [1288] | Gastrointestinal Adverse Events withGlucagon-like Peptide-1 Receptor Agonist in Type2 Diabetes: A Comprehensive Meta-analysis ofRandomised Controlled Trials and Refining Signalsthrough Pharmacovigilance Analysis
  2024 ISPE Annual Meeting 2024
  +Save